Inflation Is Driving Workers to Review Benefit Choices

U.S. workers are feeling financially stressed because of inflation and want help from their employers to make optimal benefit selections.

According to new Voya research, 70% of American employees surveyed expect to spend additional time reviewing their benefit selections because of inflation this open-enrollment season.

“With inflation at record levels not experienced in decades, the financial stress caused by increasing prices is taking a toll on American workers,” Rob Grubka, CEO of health solutions at Voya Financial, said in a statement. “With the fall open enrollment season approaching for millions of Americans, it’s encouraging to see that workers intend to carve out more time to focus on reviewing all the workplace benefits offered by their employers to help optimize every hard-earned dollar.”

Never miss a story — sign up for PLANSPONSOR newsletters to keep up on the latest retirement plan benefits news.

The research found that 74% of workers feel more stressed about their personal financial situation because of inflation, compared with 66% in March, and 70% of employees want support from their employer to make the optimal benefits selections across retirement savings, health care, health savings accounts and voluntary benefits like critical illness, hospital indemnity, disability income or accident insurance.  

“For employers and benefits providers, this presents a tremendous opportunity to work together to help simplify and personalize the annual enrollment experience so employees can act with confidence in how they allocate their next dollar,” Andrew Frend, senior vice president of strategy and product at Voya health solutions, said in a statement. “In addition to year-round education and communications efforts, innovative solutions and technology can be a game-changer.”

The research also found that 88% of Americans surveyed said widespread effects from inflation—38% cited the rising cost of food and groceries, 35% cited increasing gas prices and 15% said the cost of housing—are what worries them the most.

Inflation’s effects have also driven some employers to alter their budgets for medical and voluntary benefits spending this open-enrollment season—often held in the fall or near the end of the calendar year—when workers select benefits for the year.

The Voya survey was conducted online from June 17 to 21 by Ipsos. Data was gathered from 1,005 adults, including 495 U.S. workers over age 18.

Throughout the COVID-19 pandemic, Voya surveys have collected consumer insights examining how Americans are feeling about their personal finances, student loan debt, workplace benefits, retirement plans and other benefits and savings topics.

Appeals Court Backs Dismissal of J&J Stock-Drop Litigation

Plaintiffs in the now-dismissed case sought to establish that ‘corporate-insider fiduciaries’ violated their duties of prudence in the operation of an employee stock ownership plan.

The 3rd U.S. Circuit Court of Appeals has issued a new ruling in an Employee Retirement Income Security Act stock-drop lawsuit targeting Johnson & Johnson, affirming the dismissal of the lawsuit as ordered by a district court in May 2020.

The controversy at the heart of the litigation is related to allegations that J&J concealed that its baby powder was contaminated with asbestos and the impact of these allegations on the company’s stock price.

Never miss a story — sign up for PLANSPONSOR newsletters to keep up on the latest retirement plan benefits news.

As the appellate ruling recounts, J&J offers an employee stock ownership plan as an investment option within its retirement savings program for employees. The ESOP invests solely in J&J stock, which declined in price following news reports that accused J&J of concealing the contamination of its baby powder. J&J has denied that its product was contaminated and that it had concealed anything about the product, but the company has been embroiled in various lawsuits and investigations into the matter.

The plaintiffs, who are J&J employees who participated in the ESOP, alleged that the ESOP’s administrators, who are senior officers of J&J, violated their fiduciary duties by failing to protect the ESOP’s beneficiaries from a stock-price drop. According to the plaintiffs, those fiduciaries, being corporate insiders, should have seen the price drop coming because of the baby powder controversy. Thus, the plaintiffs alleged that the “corporate-insider fiduciaries” violated the duty of prudence imposed on them by ERISA.

The U.S. District Court for the District of New Jersey previously granted the company’s motion to dismiss the litigation, primarily on the basis that the plaintiffs did not sufficiently allege an alternative course of action that their plan fiduciaries could have taken. This is what is required under key precedents set by the U.S. Supreme Court. The district judge determined that the participants’ alleged course of alternative action would have involved actions taken by plan officials in their “corporate capacities,” rather than in their capacity as fiduciaries of the plan.

The new appellate ruling, which stretches to a little over 20 pages, backs the rationale and conclusions of the District Court.

As the appellate ruling states, in Fifth Third Bancorp v. Dudenhoeffer, the Supreme Court held that a plaintiff seeking to bring such a claim must plausibly allege “an alternative action that the defendant could have taken that would have been consistent with the securities laws,” and, further, “that a prudent fiduciary in the same circumstances would not have viewed [the proposed alternative action] as more likely to harm the fund than to help it.”

In this case, the plaintiffs proposed two alternative actions that they say the defendants could have taken before the stock price dropped. First, they proposed that the defendants could have used their corporate powers to make public disclosures that would have corrected J&J’s artificially high stock price earlier rather than later. Second, they proposed that the fiduciaries could have stopped investing in J&J stock and simply held onto all ESOP contributions as cash.

“The district court rejected those alternative actions as failing the Dudenhoeffer test, and we agree,” the appellate ruling states. “A reasonable fiduciary in the defendants’ circumstances could readily view corrective disclosures or cash holdings as being likely to do more harm than good to the ESOP, particularly given the uncertainty about J&J’s future liabilities and the future movement of its stock price. We will therefore affirm the dismissal of the plaintiffs’ complaint.”

In explaining its decision, the appeals court points out that, under Dudenhoeffer, a stock-drop plaintiff must do more than allege a general economic theory for why earlier disclosure would have been preferable. Furthermore, the plaintiff must plausibly allege that the circumstances do not justify a prudent fiduciary’s preference to await the results of a thorough investigation into the matter before making public disclosure.

The ruling notes this is a “high bar to clear” even at the pleadings stage, especially when guesswork is involved, as it is when estimating the effect of earlier versus later public disclosure of information which is itself fluid.

“Only one post-Dudenhoeffer decision from our sister circuits has held that a plaintiff plausibly alleged that corrective disclosures were so clearly beneficial that no prudent corporate-insider fiduciary could have concluded that earlier corrective disclosures would have done more harm than good,” the appellate ruling states.

Here, the ruling refers to Jander v. Retirement Plans Committee of IBM. In that case, IBM had sought to sell its microelectronics business, which was having financial trouble and was on track to incur annual losses of $700 million. Instead of disclosing these problems, IBM publicly valued the business at $2 billion, as the ruling recounts. Once IBM found a buyer, it finally disclosed that it would pay $1.5 billion to have the buyer take the business off its hands and that it would also incur “a $4.7 billion pre-tax charge, reflecting in part an impairment in the stated value” of the business being sold. IBM’s stock price steeply declined, and participants in its ESOP brought a lawsuit alleging that the plan’s corporate-insider fiduciaries knew about the undisclosed problems with the microelectronics business but imprudently continued to invest in shares of IBM stock, the price of which reflected the market’s lack of relevant knowledge.

The plaintiffs in that case alleged that the corporate-insider fiduciaries should have made an early corrective disclosure, and the 2nd U.S. Circuit Court held that the plaintiffs had met Dudenhoeffer’s standard for a duty-of-prudence claim based on inside information. In the 2nd Circuit’s view, as summarized in the new 3rd Circuit ruling, it was “particularly important” that the defendants allegedly knew that disclosure of the financial problems was inevitable.

As the new appellate ruling explains, “Unlike in the ‘normal case,’ where a prudent fiduciary might compare the benefits of disclosure versus nondisclosure, a prudent fiduciary in the Jander defendants’ circumstances could only compare earlier disclosure versus later disclosure, because once IBM knew its sale of its microelectronics business was inevitable, ‘non-disclosure of IBM’s troubles was no longer a realistic option.’” Thus, the 2nd Circuit concluded that a stock-drop following early disclosure would be no more harmful than the inevitable stock drop that would occur following a later disclosure.

“The plaintiffs ask that we follow Jander, but their complaint relies too much on general economic theory and too little on specific allegations that would establish that no prudent fiduciary in the defendants’ circumstances would believe that making corrective disclosures would do more harm than good,” the new ruling concludes.

«